ORKA FY 2020 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$93,000

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-8.40

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$50M

Total Liabilities

$4M

Stockholders' Equity

$47M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$93,000	-$89,000	-4.5%
Operating Income	-$10M	-$6M	-68.0%
Net Income	-$10M	-$5M	-77.6%